Santopaolo, Marianna (2017) Inflammation in chronic degenerative disorders: A novel CD3+CD56+ subset that regulates CD8+ T cell effector function. [Tesi di dottorato]

[thumbnail of Revised Version Santopaolo thesis PhD.pdf]
Preview
Text
Revised Version Santopaolo thesis PhD.pdf

Download (1MB) | Preview
Item Type: Tesi di dottorato
Resource language: English
Title: Inflammation in chronic degenerative disorders: A novel CD3+CD56+ subset that regulates CD8+ T cell effector function.
Creators:
Creators
Email
Santopaolo, Marianna
SANTOPAOLOMARIANNA@GMAIL.COM
Date: 6 April 2017
Number of Pages: 51
Institution: Università degli Studi di Napoli Federico II
Department: Medicina Molecolare e Biotecnologie Mediche
Dottorato: Medicina molecolare e biotecnologie mediche
Ciclo di dottorato: 29
Coordinatore del Corso di dottorato:
nome
email
Avvedimento, Vittorio Enrico
vittorioenrico.avvedimento@unina.it
Tutor:
nome
email
Tramontano, Donatella
UNSPECIFIED
Date: 6 April 2017
Number of Pages: 51
Keywords: T1D, CD3+CD56+
Settori scientifico-disciplinari del MIUR: Area 06 - Scienze mediche > MED/04 - Patologia generale
Date Deposited: 03 May 2017 08:48
Last Modified: 13 Mar 2018 11:27
URI: http://www.fedoa.unina.it/id/eprint/11557
DOI: 10.6093/UNINA/FEDOA/11557

Collection description

It has been reported that a growing and heterogeneous group of regulatory cell modulate immune response. In particular, regulation of CD8+ T lymphocyte effector functions is critical for tissue homeostasis and immune tolerance control. Here, we report that the co-expression of CD3 and CD56 molecules identify a novel human regulatory T cell population exerting suppressive activity on proliferation, cytotoxicity and IFN- production of TCR-activated human CD8+ T lymphocytes. Regulatory functions of human circulating CD3+CD56+ T lymphocytes require cell-to-cell contact and are exerted in both autologous and allogeneic conditions. Of note, CD3+CD56+ T cells are reduced and functionally impaired in children affected by Type 1 Diabetes (T1D), at disease onset. Conversely the frequency of this cell subset is increased in patients with prostate cancer. Taken together, our findings reveal that freshly isolated human CD3+CD56+ cells specifically control activation of human CD8+ T lymphocytes. Perturbation of number and function of this cell subset may account for the deranged functions of CD8+ T lymphocytes observed in autoimmune conditions, including T1D. Thus, therapeutic manipulation of CD3+CD56+ cells may represent an innovative approach to restore immune function in T1D.

Downloads

Downloads per month over past year

Actions (login required)

View Item View Item